Indap (Indapamide)

Indapamide inhibits the Na⁺/Cl⁻ symporter in the distal convoluted tubule, decreasing sodium and chloride reabsorption. This leads to increased urinary loss of sodium (natriuresis) and water (diuresis), which reduces extracellular fluid volume and peripheral vascular resistance, thereby lowering blood pressure.

The appropriate dose of indapamide is determined by the prescribing clinician based on the individual patient's condition, response, and renal function. Dosage may vary, and patients should follow the specific instructions provided by their healthcare professional.

Safety data for indapamide during pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit outweighs the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To order Indap, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indapamide belongs to the thiazide‑like class, offering potent antihypertensive and diuretic effects with a relatively favorable metabolic profile compared with some loop diuretics. It provides longer‑lasting blood‑pressure control and may cause fewer disturbances in potassium levels than traditional thiazides, though individual response varies.

Indap tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original packaging to protect from moisture and light, and ensure the container is tightly closed. Do not store in extreme heat or humidity to maintain product stability.

Indap is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the specific timing instructions given by their prescriber. Swallow the tablet whole; do not crush or chew unless directed by a healthcare professional.

Serious risks include severe dehydration, electrolyte imbalances such as hyponatremia or hypokalemia, acute kidney injury, and marked drops in blood pressure that can cause dizziness or fainting. Patients should report sudden weakness, irregular heartbeat, severe muscle cramps, or any signs of allergic reaction promptly.

Indap should be avoided in patients with known hypersensitivity to indapamide or other sulfonamide diuretics, those with severe renal or hepatic impairment, and individuals with uncontrolled electrolyte disturbances. Caution is also advised for patients on lithium therapy or those taking multiple antihypertensive agents.